Oral 7: What’s New in the Treatment of Giant Cell Tumor of Bone?
Moderator:

Prof. Vivek Ajit Singh (University Malaya, Malaysia),

Dr. Chia-Chun Wu (Tri-Service General Hospital, Taiwan)

Special Lecture:

CURRENT UPDATES IN THE MANAGEMENT OF GCT AND THE ROLE OF DENOSUMAB

Prof. Ajay Puri(Tata Memorial Hospital, India)

Paper Number Paper Title Speaker/Moderator Organization Country
07-1 OUTCOMES AND RISK FACTORS OF PULMONARY METASTASIS FROM GIANT CELL TUMOR OF BONE Dr. Thanate Poosiripinyo Khon Kaen Hospital Thailand
07-2 COMPARING CLINICAL EFFICACY OF BIO SIMILAR TO ORIGINAL MOLECULE IN SHORT COURSE USE OF NEOADJUVANT DENOSUMAB IN GIANT CELL TUMOUR OF BONE Prof. Ajay Puri Tata Memorial Hospital India
07-3 A RETROSPECTIVE COHORT STUDY OF PREOPERATIVE ZOLENDRONATE VERSUS DENOSUMAB IN EXTREMITY GIANT CELL TUMOR OF BONE TREATED WITH INTRALESIONAL CURETTAGE AND CEMENTATION: A PROPOSAL OF A RATIONAL TREATMENT APPROACH Dr. On-Fai Woo Prince of Wales Hospital Hong Kong
07-4 NOVEL BIOMARKERS FOR THE THERAPEUTIC EFFECT OF DENOSUMAB ON GIANT CELL TUMORS OF BONE: PREDICTING BONE FORMATION AFTER DENOSUMAB ADMINISTRATION THROUGH Β-CATENIN STAINING Prof. Yoshihiro Matsumoto Fukushima Medical University Japan
07-5 THE DIAGNOSTIC AND PROGNOSTIC VALUE OF TARTRATE-RESISTANT ACID PHOSPHATASE ISOFORM 5B FOR GIANT CELL TUMOR OF BONE Dr. Yu Toda National Cancer Center Hospital Japan
07-6 EFFECT OF DENOSUMAB ON BIOLOGICAL BEHAVIOR OF TUMOR STROMAL CELLS OF GCTB Dr. Chao-Ming Chen Therapeutical and Research Center of Musculoskeletal Tumor, Taipei Veterans General Hospital Taiwan
07-7 FUNCTIONAL OUTCOME OF ULNAR TRANSLOCATION AFTER EN BLOC RESECTION OF GIANT CELL TUMOR OF DISTAL RADIUS CAMPANACCI GRADE 3 Dr. Muhammad Johan Indonesia Musculoskeletal Tumor Society Indonesia
07-8 A PROPOSED REACT – ZA / D: RADIOLOGICAL EXAMINATION AND ANALYSIS WITH VARIOUS CRITERIA FOR GCT OF BONE TREATED WITH ZOLENDRONIC ACID / DENOSUMAB Dr. Abhijeet Salunke The Gujarat Cancer and Research Institute (gcri) India
07-9 GIANT CELL TUMOR GRADE III & DENOSUMAB EFFECTS; PROSPECTIVE STUDY ON 127 PATIENTS. Prof. Dr Badaruddin Sahito Dow University Of Health Sciences / Dr Ruth Km Pfau Civil Hospital Karachi Pakistan
07-10 INCIDENCE OF GIANT CELL TUMOR OF BONE (GCTB) IN THE PHILIPPINES: PHILIPPINE MUSCULOSKELETAL TUMOR SOCIETY MULTI-CENTER STUDY ON TREATMENT DURING THE COVID-19 PANDEMIC Dr. Abigail Tud Taipei Veterans General Hospital Taiwan
07-11 CT IMAGING FEATURES OF LOCAL RECURRENCE AFTER EXTENDED CURETTAGE FOR GIANT CELL TUMOR OF BONE AROUND THE KNEE JOINT Dr. Ting Yuan Shanghai Jiao Tong University Affiliated Sixth
People’s Hospital
China
07-12 GIANT CELL TUMOR OF BONE AND PREGNANCY: A STUDY BY THE EASTERN ASIAN MUSCULOSKELETAL ONCOLOGY GROUP Dr. Min Wook Joo The Catholic University of Korea South Korea
07-13 PROFILE OF GIANT CELL TUMOR IN DR. SOETOMO GENERAL ACADEMIC HOSPITAL, INDONESIA. FIVE YEARS EXPERIENCE Mrs. Sjahjenny Mustokoweni Dr. Soetomo General Academic Hospital Indonesia
Q&A / Panel
Discussion